JP2015527057A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015527057A5 JP2015527057A5 JP2015517896A JP2015517896A JP2015527057A5 JP 2015527057 A5 JP2015527057 A5 JP 2015527057A5 JP 2015517896 A JP2015517896 A JP 2015517896A JP 2015517896 A JP2015517896 A JP 2015517896A JP 2015527057 A5 JP2015527057 A5 JP 2015527057A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- constitutive
- genome
- cutoff value
- locus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 58
- 206010028980 Neoplasm Diseases 0.000 claims 18
- 108020004414 DNA Proteins 0.000 claims 16
- 239000012472 biological sample Substances 0.000 claims 12
- 201000011510 cancer Diseases 0.000 claims 8
- 239000012634 fragment Substances 0.000 claims 8
- 239000000523 sample Substances 0.000 claims 6
- 108090000623 proteins and genes Proteins 0.000 claims 5
- 230000035772 mutation Effects 0.000 claims 4
- 238000012163 sequencing technique Methods 0.000 claims 3
- 108091035707 Consensus sequence Proteins 0.000 claims 2
- 230000002601 intratumoral effect Effects 0.000 claims 2
- 238000005259 measurement Methods 0.000 claims 2
- 210000004881 tumor cell Anatomy 0.000 claims 2
- 108700028369 Alleles Proteins 0.000 claims 1
- 206010003445 Ascites Diseases 0.000 claims 1
- 208000006994 Precancerous Conditions Diseases 0.000 claims 1
- 210000003567 ascitic fluid Anatomy 0.000 claims 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims 1
- 230000001973 epigenetic effect Effects 0.000 claims 1
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 210000004910 pleural fluid Anatomy 0.000 claims 1
- 210000003296 saliva Anatomy 0.000 claims 1
- 210000001138 tear Anatomy 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018132118A JP6930948B2 (ja) | 2012-06-21 | 2018-07-12 | 癌検出のための血漿中ｄｎａの突然変異解析 |
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261662878P | 2012-06-21 | 2012-06-21 | |
| US61/662,878 | 2012-06-21 | ||
| US201261682725P | 2012-08-13 | 2012-08-13 | |
| US61/682,725 | 2012-08-13 | ||
| US201261695795P | 2012-08-31 | 2012-08-31 | |
| US61/695,795 | 2012-08-31 | ||
| US201261711172P | 2012-10-08 | 2012-10-08 | |
| US61/711,172 | 2012-10-08 | ||
| US13/801,748 | 2013-03-13 | ||
| US13/801,748 US11261494B2 (en) | 2012-06-21 | 2013-03-13 | Method of measuring a fractional concentration of tumor DNA |
| PCT/IB2013/054898 WO2013190441A2 (en) | 2012-06-21 | 2013-06-14 | Mutational analysis of plasma dna for cancer detection |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018132118A Division JP6930948B2 (ja) | 2012-06-21 | 2018-07-12 | 癌検出のための血漿中ｄｎａの突然変異解析 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015527057A JP2015527057A (ja) | 2015-09-17 |
| JP2015527057A5 true JP2015527057A5 (enExample) | 2017-10-19 |
| JP6371280B2 JP6371280B2 (ja) | 2018-08-08 |
Family
ID=52274459
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015517896A Active JP6371280B2 (ja) | 2012-06-21 | 2013-06-14 | 癌検出のための血漿中ｄｎａの突然変異解析 |
| JP2018132118A Expired - Fee Related JP6930948B2 (ja) | 2012-06-21 | 2018-07-12 | 癌検出のための血漿中ｄｎａの突然変異解析 |
| JP2021131682A Active JP7408161B2 (ja) | 2012-06-21 | 2021-08-12 | 癌検出のための血漿中ｄｎａの突然変異解析 |
| JP2023210140A Pending JP2024026360A (ja) | 2012-06-21 | 2023-12-13 | 癌検出のための血漿中ｄｎａの突然変異解析 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018132118A Expired - Fee Related JP6930948B2 (ja) | 2012-06-21 | 2018-07-12 | 癌検出のための血漿中ｄｎａの突然変異解析 |
| JP2021131682A Active JP7408161B2 (ja) | 2012-06-21 | 2021-08-12 | 癌検出のための血漿中ｄｎａの突然変異解析 |
| JP2023210140A Pending JP2024026360A (ja) | 2012-06-21 | 2023-12-13 | 癌検出のための血漿中ｄｎａの突然変異解析 |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US11261494B2 (enExample) |
| EP (4) | EP2864501B1 (enExample) |
| JP (4) | JP6371280B2 (enExample) |
| KR (7) | KR102096611B1 (enExample) |
| CN (3) | CN107779506B (enExample) |
| AU (4) | AU2013278994C1 (enExample) |
| CA (2) | CA2876327C (enExample) |
| DK (2) | DK2864501T3 (enExample) |
| EA (2) | EA037292B1 (enExample) |
| ES (2) | ES2687847T3 (enExample) |
| HU (1) | HUE056915T2 (enExample) |
| IL (5) | IL311127B2 (enExample) |
| MX (3) | MX360264B (enExample) |
| PT (1) | PT3456843T (enExample) |
| SG (2) | SG11201408113QA (enExample) |
| TW (4) | TWI636255B (enExample) |
| WO (1) | WO2013190441A2 (enExample) |
| ZA (1) | ZA201409281B (enExample) |
Families Citing this family (129)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
| US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US12054776B2 (en) | 2007-07-23 | 2024-08-06 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing |
| EP3216874A1 (en) | 2008-09-05 | 2017-09-13 | TOMA Biosciences, Inc. | Methods for stratifying and annotating cancer drug treatment options |
| US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
| US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US12655483B2 (en) | 2010-05-18 | 2026-06-16 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US12152275B2 (en) | 2010-05-18 | 2024-11-26 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US12221653B2 (en) | 2010-05-18 | 2025-02-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| AU2011305445B2 (en) | 2010-09-24 | 2017-03-16 | The Board Of Trustees Of The Leland Stanford Junior University | Direct capture, amplification and sequencing of target DNA using immobilized primers |
| EP3225697A3 (en) | 2010-12-30 | 2017-11-22 | Foundation Medicine, Inc. | Optimization of multigene analysis of tumor samples |
| JP6153874B2 (ja) | 2011-02-09 | 2017-06-28 | ナテラ， インコーポレイテッド | 非侵襲的出生前倍数性呼び出しのための方法 |
| US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
| US11261494B2 (en) | 2012-06-21 | 2022-03-01 | The Chinese University Of Hong Kong | Method of measuring a fractional concentration of tumor DNA |
| US20150011396A1 (en) | 2012-07-09 | 2015-01-08 | Benjamin G. Schroeder | Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing |
| US20140100126A1 (en) | 2012-08-17 | 2014-04-10 | Natera, Inc. | Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data |
| US11913065B2 (en) | 2012-09-04 | 2024-02-27 | Guardent Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US10876152B2 (en) | 2012-09-04 | 2020-12-29 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| PL2893040T3 (pl) | 2012-09-04 | 2019-05-31 | Guardant Health Inc | Sposoby wykrywania rzadkich mutacji i wariantu liczby kopii |
| US20160040229A1 (en) | 2013-08-16 | 2016-02-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US20130309666A1 (en) | 2013-01-25 | 2013-11-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| EP2971130A4 (en) | 2013-03-15 | 2016-10-05 | Nugen Technologies Inc | SEQUENTIAL SEQUENCING |
| US20160032396A1 (en) * | 2013-03-15 | 2016-02-04 | The Board Of Trustees Of The Leland Stanford Junior University | Identification and Use of Circulating Nucleic Acid Tumor Markers |
| JP6525473B2 (ja) | 2013-11-13 | 2019-06-05 | ニューゲン テクノロジーズ， インコーポレイテッド | 複製物配列決定リードを同定するための組成物および方法 |
| CN111534580B (zh) | 2013-12-28 | 2024-06-04 | 夸登特健康公司 | 用于检测遗传变异的方法和系统 |
| US12492429B2 (en) * | 2014-04-21 | 2025-12-09 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
| RU2717641C2 (ru) | 2014-04-21 | 2020-03-24 | Натера, Инк. | Обнаружение мутаций и плоидности в хромосомных сегментах |
| US20180173845A1 (en) | 2014-06-05 | 2018-06-21 | Natera, Inc. | Systems and Methods for Detection of Aneuploidy |
| TWI758011B (zh) | 2014-07-18 | 2022-03-11 | 香港中文大學 | Ｄｎａ混合物中之組織甲基化模式分析 |
| CN107002122B (zh) * | 2014-07-25 | 2023-09-19 | 华盛顿大学 | 确定导致无细胞dna的产生的组织和/或细胞类型的方法以及使用其鉴定疾病或紊乱的方法 |
| EP3177740B1 (en) * | 2014-08-06 | 2021-01-13 | Nugen Technologies, Inc. | Digital measurements from targeted sequencing |
| SI3198026T1 (sl) * | 2014-08-07 | 2020-02-28 | Pharmassist Ltd | Metoda za analiziranje DNA PIK3CA mutantnega statusa v vzorcu |
| US12391985B2 (en) | 2014-08-07 | 2025-08-19 | Pharmassist Ltd | Method of determining PIK3CA mutational status in a sample |
| WO2016040901A1 (en) | 2014-09-12 | 2016-03-17 | The Board Of Trustees Of The Leland Stanford Junior University | Identification and use of circulating nucleic acids |
| ES2989276T3 (es) * | 2014-12-05 | 2024-11-25 | Found Medicine Inc | Análisis multigénico de muestras tumorales |
| DK3230469T3 (da) | 2014-12-12 | 2019-07-15 | Verinata Health Inc | Anvendelse af cellefri DNA-fragmentstørrelse til bestemmelse af kopiantalsvariationer |
| WO2016109452A1 (en) | 2014-12-31 | 2016-07-07 | Guardant Health , Inc. | Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results |
| US10364467B2 (en) | 2015-01-13 | 2019-07-30 | The Chinese University Of Hong Kong | Using size and number aberrations in plasma DNA for detecting cancer |
| DK3256605T3 (da) * | 2015-02-10 | 2022-03-14 | Univ Hong Kong Chinese | Påvisning af mutationer til cancerscreening og føtal analyse |
| EP3288455B1 (en) * | 2015-05-01 | 2023-12-06 | Guardant Health, Inc. | Diagnostic methods |
| EP4428863A3 (en) | 2015-05-11 | 2024-12-11 | Natera, Inc. | Methods and compositions for determining ploidy |
| CN104894268B (zh) * | 2015-06-05 | 2018-02-09 | 上海美吉生物医药科技有限公司 | 定量样本中源自细胞凋亡的dna浓度的方法及其应用 |
| CN107849556A (zh) * | 2015-07-01 | 2018-03-27 | 学校法人庆应义塾 | 癌组织的异质性标记物及其使用 |
| JP2017016665A (ja) * | 2015-07-03 | 2017-01-19 | 国立大学法人東北大学 | 配列のデータからの変異情報の選択方法、システム、及び、コンピュータプログラム |
| WO2017012544A1 (en) | 2015-07-20 | 2017-01-26 | The Chinese University Of Hong Kong | Methylation pattern analysis of haplotypes in tissues in dna mixture |
| US10453556B2 (en) | 2015-07-23 | 2019-10-22 | The Chinese University Of Hong Kong | Analysis of fragmentation patterns of cell-free DNA |
| US11319586B2 (en) * | 2015-08-12 | 2022-05-03 | The Chinese University Of Hong Kong | Single-molecule sequencing of plasma DNA |
| US11908588B2 (en) | 2015-08-25 | 2024-02-20 | Nantomics Llc | Systems and methods for genetic analysis of metastases |
| US12540351B2 (en) * | 2015-09-02 | 2026-02-03 | Guardant Health, Inc. | Identification of somatic mutations versus germline variants for cell-free DNA variant calling applications |
| SG11201805119QA (en) | 2015-12-17 | 2018-07-30 | Guardant Health Inc | Methods to determine tumor gene copy number by analysis of cell-free dna |
| EP4779643A2 (en) * | 2016-02-02 | 2026-07-22 | Guardant Health, Inc. | Cancer evolution detection and diagnostic |
| US10095831B2 (en) | 2016-02-03 | 2018-10-09 | Verinata Health, Inc. | Using cell-free DNA fragment size to determine copy number variations |
| KR101810528B1 (ko) * | 2016-03-29 | 2017-12-21 | 한국과학기술원 | 단백질을 변화시키지 않는 암 돌연변이의 기능적 recurrence를 구하는 방법 및 장치 |
| WO2017181146A1 (en) * | 2016-04-14 | 2017-10-19 | Guardant Health, Inc. | Methods for early detection of cancer |
| JP7280044B2 (ja) | 2016-04-15 | 2023-05-23 | ナテラ， インコーポレイテッド | 肺癌の検出方法 |
| GB2555765A (en) * | 2016-05-01 | 2018-05-16 | Genome Res Ltd | Method of detecting a mutational signature in a sample |
| US12062416B2 (en) | 2016-05-01 | 2024-08-13 | Genome Research Limited | Method of characterizing a DNA sample |
| WO2017191074A1 (en) | 2016-05-01 | 2017-11-09 | Genome Research Limited | Method of characterising a dna sample |
| CN105969656B (zh) * | 2016-05-13 | 2019-09-10 | 万康源(天津)基因科技有限公司 | 一种单细胞外显子测序肿瘤体细胞突变检测及分析平台 |
| CN105969856B (zh) * | 2016-05-13 | 2019-11-12 | 万康源(天津)基因科技有限公司 | 一种单细胞外显子测序肿瘤体细胞突变检测方法 |
| CN106355045B (zh) * | 2016-08-30 | 2019-03-15 | 天津诺禾致源生物信息科技有限公司 | 一种基于扩增子二代测序小片段插入缺失检测的方法及装置 |
| EP3792922A1 (en) * | 2016-09-30 | 2021-03-17 | Guardant Health, Inc. | Methods for multi-resolution analysis of cell-free nucleic acids |
| TWI797095B (zh) | 2016-10-24 | 2023-04-01 | 美商格瑞爾有限責任公司 | 腫瘤檢測之方法及系統 |
| GB201618485D0 (en) * | 2016-11-02 | 2016-12-14 | Ucl Business Plc | Method of detecting tumour recurrence |
| US11142798B2 (en) * | 2016-11-17 | 2021-10-12 | GenomiCare Biotechnology (Shanghai) Co. Ltd | Systems and methods for monitoring lifelong tumor evolution field of invention |
| IL266347B2 (en) | 2016-11-30 | 2025-01-01 | Univ Hong Kong Chinese | Analysis of cell-free DNA in urine and other samples |
| CN110383385B (zh) * | 2016-12-08 | 2023-07-25 | 生命科技股份有限公司 | 从肿瘤样品中检测突变负荷的方法 |
| CN106845153A (zh) * | 2016-12-29 | 2017-06-13 | 安诺优达基因科技(北京)有限公司 | 一种用于利用循环肿瘤dna样本检测体细胞突变的装置 |
| CN106874710A (zh) * | 2016-12-29 | 2017-06-20 | 安诺优达基因科技(北京)有限公司 | 一种用于利用肿瘤ffpe样本检测体细胞突变的装置 |
| WO2018137685A1 (en) | 2017-01-25 | 2018-08-02 | The Chinese University Of Hong Kong | Diagnostic applications using nucleic acid fragments |
| US12492430B2 (en) | 2017-04-11 | 2025-12-09 | Tecan Genomics, Inc. | Library quantitation and qualification |
| US11342047B2 (en) * | 2017-04-21 | 2022-05-24 | Illumina, Inc. | Using cell-free DNA fragment size to detect tumor-associated variant |
| CN118711654A (zh) * | 2017-05-16 | 2024-09-27 | 夸登特健康公司 | 无细胞dna的体细胞来源或种系来源的鉴定 |
| KR102145417B1 (ko) * | 2017-05-24 | 2020-08-19 | 지니너스 주식회사 | 무세포 핵산으로부터 수득된 서열 분석 데이터에 대한 배경 대립인자의 빈도 분포를 생성하는 방법 및 이를 이용하여 무세포 핵산으로부터 변이를 검출하는 방법 |
| WO2019020057A1 (en) | 2017-07-26 | 2019-01-31 | The Chinese University Of Hong Kong | ENHANCING CANCER SCREENING WITH ACELLULAR VIRAL NUCLEIC ACIDS |
| EP3682035B1 (en) * | 2017-09-15 | 2025-02-05 | The Regents of the University of California | Detecting somatic single nucleotide variants from cell-free nucleic acid with application to minimal residual disease monitoring |
| KR20240157126A (ko) * | 2017-09-20 | 2024-10-31 | 가던트 헬쓰, 인크. | 체세포 및 생식세포계열 변이체를 구별하기 위한 방법 및 시스템 |
| KR20200044123A (ko) * | 2017-10-10 | 2020-04-28 | 난토믹스, 엘엘씨 | 암 환자에서의 향상된 정밀도를 위한 포괄적 게놈 트랜스크립톰 종양-정상 유전자 패널 분석 (comprehensive genomic transcriptomic tumor-normal gene panel analysis for enhanced precision in patients with cancer) |
| US11099202B2 (en) | 2017-10-20 | 2021-08-24 | Tecan Genomics, Inc. | Reagent delivery system |
| EP3704268B1 (en) | 2017-11-03 | 2025-01-22 | Guardant Health, Inc. | Normalizing tumor mutation burden |
| EP3718113B1 (en) * | 2017-11-30 | 2025-07-02 | Illumina, Inc. | Validation methods and systems for sequence variant calls |
| WO2019118926A1 (en) | 2017-12-14 | 2019-06-20 | Tai Diagnostics, Inc. | Assessing graft suitability for transplantation |
| EP3737773B1 (en) | 2018-01-12 | 2023-04-12 | Natera, Inc. | Novel primers and uses thereof |
| US20190249229A1 (en) * | 2018-02-12 | 2019-08-15 | Nant Holdings Ip, Llc | Bam signatures from liquid and solid tumors and uses therefor |
| US12626780B2 (en) | 2018-03-13 | 2026-05-12 | Grail, Inc. | Method and system for selecting, managing, and analyzing data of high dimensionality |
| DK3781714T3 (da) | 2018-04-14 | 2026-03-30 | Natera Inc | Fremgangsmåder til cancerpåvisning og -overvågning ved personlig påvisning af cirkulerende tumor-dna |
| CN121137125A (zh) * | 2018-04-16 | 2025-12-16 | 格里尔公司 | 用于确定在无细胞核酸中的肿瘤分数的系统及方法 |
| CN112888459B (zh) | 2018-06-01 | 2023-05-23 | 格里尔公司 | 卷积神经网络系统及数据分类方法 |
| US20190385700A1 (en) * | 2018-06-04 | 2019-12-19 | Guardant Health, Inc. | METHODS AND SYSTEMS FOR DETERMINING The CELLULAR ORIGIN OF CELL-FREE NUCLEIC ACIDS |
| KR20210035167A (ko) | 2018-06-11 | 2021-03-31 | 파운데이션 메디신 인코포레이티드 | 게놈 변경을 평가하기 위한 조성물 및 방법 |
| US12234509B2 (en) | 2018-07-03 | 2025-02-25 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
| CN120193081A (zh) * | 2018-07-23 | 2025-06-24 | 夸登特健康公司 | 用于通过肿瘤分数和覆盖率调整肿瘤突变负荷的方法和系统 |
| CN112424380B (zh) | 2018-11-01 | 2025-03-04 | Illumina公司 | 用于体细胞变体检测的方法和组合物 |
| JP7499239B2 (ja) * | 2018-11-13 | 2024-06-13 | ミリアド・ジェネティックス・インコーポレイテッド | 体細胞変異のための方法およびシステム、ならびにそれらの使用 |
| US11581062B2 (en) | 2018-12-10 | 2023-02-14 | Grail, Llc | Systems and methods for classifying patients with respect to multiple cancer classes |
| CN113366122B (zh) | 2018-12-19 | 2024-01-12 | 香港中文大学 | 游离dna末端特征 |
| US20200219587A1 (en) * | 2018-12-21 | 2020-07-09 | Grail, Inc. | Systems and methods for using fragment lengths as a predictor of cancer |
| CN109616198A (zh) * | 2018-12-28 | 2019-04-12 | 陈洪亮 | 仅用于肝癌单一癌种筛查的特异甲基化检测位点组合的选取方法 |
| CN109686414A (zh) * | 2018-12-28 | 2019-04-26 | 陈洪亮 | 仅用于肝癌筛查的特异甲基化检测位点组合的选取方法 |
| CN109817279B (zh) * | 2019-01-18 | 2022-11-04 | 臻悦生物科技江苏有限公司 | 肿瘤突变负荷的检测方法、装置、存储介质及处理器 |
| KR102381252B1 (ko) * | 2019-02-19 | 2022-04-01 | 주식회사 녹십자지놈 | 혈중 무세포 dna 기반 간암 치료 예후예측 방법 |
| CN109841265B (zh) * | 2019-02-22 | 2021-09-21 | 清华大学 | 使用片段化模式确定血浆游离核酸分子组织来源的方法和系统及应用 |
| CN109920480B (zh) * | 2019-03-14 | 2020-02-21 | 深圳市海普洛斯生物科技有限公司 | 一种校正高通量测序数据的方法和装置 |
| CN111755075B (zh) * | 2019-03-28 | 2023-09-29 | 深圳华大生命科学研究院 | 对免疫组库高通量测序样本间序列污染进行过滤的方法 |
| US12497662B2 (en) | 2019-04-16 | 2025-12-16 | Grail, Inc. | Systems and methods for tumor fraction estimation from small variants |
| KR20220031860A (ko) | 2019-05-03 | 2022-03-14 | 울티마 제노믹스, 인크. | 핵산 변이체를 검출하는 방법 |
| US12437839B2 (en) | 2019-05-03 | 2025-10-07 | Ultima Genomics, Inc. | Methods for detecting nucleic acid variants |
| WO2020236630A1 (en) * | 2019-05-17 | 2020-11-26 | Ultima Genomics, Inc. | Methods and systems for detecting residual disease |
| CA3140066A1 (en) * | 2019-05-20 | 2020-11-26 | Foundation Medicine, Inc. | Systems and methods for evaluating tumor fraction |
| EP3795685A1 (en) | 2019-09-20 | 2021-03-24 | Sophia Genetics S.A. | Methods for dna library generation to facilitate the detection and reporting of low frequency variants |
| CN111223525A (zh) * | 2020-01-07 | 2020-06-02 | 广州基迪奥生物科技有限公司 | 一种肿瘤外显子测序数据分析方法 |
| EP3851542A1 (en) | 2020-01-20 | 2021-07-21 | Tecan Genomics, Inc. | Depletion of abundant uninformative sequences |
| CN113275053A (zh) | 2020-02-03 | 2021-08-20 | 帝肯基因组学公司 | 试剂存储系统 |
| US11475981B2 (en) | 2020-02-18 | 2022-10-18 | Tempus Labs, Inc. | Methods and systems for dynamic variant thresholding in a liquid biopsy assay |
| US11211147B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing |
| US11211144B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Methods and systems for refining copy number variation in a liquid biopsy assay |
| CN117063239A (zh) * | 2021-03-05 | 2023-11-14 | 夸登特健康公司 | 用于分析分子响应的方法和相关方面 |
| JP7022861B1 (ja) * | 2021-06-25 | 2022-02-18 | 株式会社日立パワーソリューションズ | アレイ型超音波送受信装置 |
| US20240321396A1 (en) * | 2021-06-30 | 2024-09-26 | Memorial Sloan-Kettering Cancer Center | Detection of somatic mutational signatures from whole genome sequencing of cell-free dna |
| WO2023284260A1 (zh) * | 2021-07-12 | 2023-01-19 | 广州燃石医学检验所有限公司 | 基于血液测序的肿瘤内异质性的评估方法及其用于预测免疫疗法的应答 |
| KR102935486B1 (ko) * | 2021-12-06 | 2026-03-10 | 주식회사 지씨지놈 | 혈중 무세포 dna 기반 유방암 치료 예후예측 방법 |
| CN115064212B (zh) * | 2022-06-24 | 2023-03-14 | 哈尔滨星云生物信息技术开发有限公司 | 基于wgs数据的预设区域人群肿瘤特异突变识别方法 |
| WO2024003936A1 (en) | 2022-06-29 | 2024-01-04 | Raman Govindarajan | Method for detecting cancer susceptibility, early detection and predicting cancer behaviour |
| KR102923761B1 (ko) * | 2022-10-13 | 2026-02-04 | 인하대학교 산학협력단 | cfDNA의 구조 변이 서열 검출을 통한 미세잔존질환 진단 방법 |
| CN117012274B (zh) * | 2023-10-07 | 2024-01-16 | 北京智因东方转化医学研究中心有限公司 | 基于高通量测序识别基因缺失的装置 |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE399793T1 (de) | 1999-04-02 | 2008-07-15 | Corixa Corp | Verbindungen und verfahren für therapie und diagnose von lungenkrebs |
| US20030219765A1 (en) | 2000-03-23 | 2003-11-27 | Jose Costa | Methods for evaluating cancer risk |
| US20030211522A1 (en) | 2002-01-18 | 2003-11-13 | Landes Gregory M. | Methods for fetal DNA detection and allele quantitation |
| WO2003095664A2 (en) | 2002-05-10 | 2003-11-20 | City Of Hope | Pyrophosphorolysis activated polymerization (pap) |
| US7704687B2 (en) | 2002-11-15 | 2010-04-27 | The Johns Hopkins University | Digital karyotyping |
| US20060188889A1 (en) * | 2003-11-04 | 2006-08-24 | Christopher Burgess | Use of differentially expressed nucleic acid sequences as biomarkers for cancer |
| EP1599608A4 (en) | 2003-03-05 | 2007-07-18 | Genetic Technologies Ltd | Identification of fetal DNA and fetal cell marker in maternal plasma or serum |
| PL201608B1 (pl) | 2003-06-13 | 2009-04-30 | Cezary Cybulski | Sposób i zestaw do wykrywania wysokiej genetycznie uwarunkowanej predyspozycji do raka prostaty oraz zastosowanie zmiany germinalnej w obrębie genu NBS1 |
| DE60328193D1 (de) | 2003-10-16 | 2009-08-13 | Sequenom Inc | Nicht invasiver Nachweis fötaler genetischer Merkmale |
| US20050282196A1 (en) | 2004-04-30 | 2005-12-22 | Jose Costa | Methods and compositions for cancer diagnosis |
| JP5219516B2 (ja) * | 2005-03-18 | 2013-06-26 | ザ チャイニーズ ユニバーシティー オブ ホンコン | 染色体異数性の検出方法 |
| US20070122823A1 (en) | 2005-09-01 | 2007-05-31 | Bianchi Diana W | Amniotic fluid cell-free fetal DNA fragment size pattern for prenatal diagnosis |
| WO2007092473A2 (en) | 2006-02-02 | 2007-08-16 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive fetal genetic screening by digital analysis |
| SI1996728T1 (sl) | 2006-02-28 | 2011-10-28 | Univ Louisville Res Found | Prepoznavanje kromosomskih nenormalnosti pri zarodku s pomočjo dvojnih mononukleotidnih polimorfizmov |
| WO2008024009A1 (en) | 2006-08-15 | 2008-02-28 | Institut Molekulyarnoi Genetiki Rossiiskoi Akademii Nauk (Img Ran) | Transcriptional level of a timp3 gene in the form of a diagnosis marker of a non-small cell carcinoma of lung |
| EP2535425A1 (en) | 2007-05-25 | 2012-12-19 | Decode Genetics EHF. | Variantes génétiques sur les chr 10q26 utilisées comme marqueurs dans l'évaluation, le diagnostic, le pronostic et le traitement d'un risque de cancer du sein |
| US12054776B2 (en) | 2007-07-23 | 2024-08-06 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing |
| US20090053719A1 (en) | 2007-08-03 | 2009-02-26 | The Chinese University Of Hong Kong | Analysis of nucleic acids by digital pcr |
| WO2009051842A2 (en) * | 2007-10-18 | 2009-04-23 | The Johns Hopkins University | Detection of cancer by measuring genomic copy number and strand length in cell-free dna |
| US20100041048A1 (en) | 2008-07-31 | 2010-02-18 | The Johns Hopkins University | Circulating Mutant DNA to Assess Tumor Dynamics |
| WO2010033578A2 (en) * | 2008-09-20 | 2010-03-25 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnosis of fetal aneuploidy by sequencing |
| WO2010053980A2 (en) * | 2008-11-04 | 2010-05-14 | The Johns Hopkins University | Dna integrity assay (dia) for cancer diagnostics, using confocal fluorescence spectroscopy |
| US20100136560A1 (en) | 2008-12-02 | 2010-06-03 | The Johns Hopkins University | Integrated Analyses of Breast and Colorectal Cancers |
| WO2010091046A2 (en) * | 2009-02-03 | 2010-08-12 | President & Fellows Of Harvard College | Systems and methods for high throughput, high fidelity, single molecule nucleic acid sequencing using time multiplexed excitation |
| US20120021428A1 (en) | 2009-03-31 | 2012-01-26 | Marcus Otte | Method for diagnosis of cancer and monitoring of cancer treatments |
| WO2011038507A1 (en) | 2009-10-02 | 2011-04-07 | Centre For Addiction And Mental Health | Method for analysis of dna methylation profiles of cell-free circulating dna in bodily fluids |
| WO2011053790A2 (en) | 2009-10-30 | 2011-05-05 | Fluidigm Corporation | Assay of closely linked targets in fetal diagnosis and coincidence detection assay for genetic analysis |
| LT3241914T (lt) | 2009-11-05 | 2019-04-25 | The Chinese University Of Hong Kong | Vaisiaus genomo analizė iš motinos biologinio mėginio |
| CA2780016C (en) | 2009-11-06 | 2017-09-19 | The Chinese University Of Hong Kong | Size-based genomic analysis |
| GB0922006D0 (en) | 2009-12-17 | 2010-02-03 | Genome Res Ltd | Diagnostic |
| AU2011207544A1 (en) | 2010-01-19 | 2012-09-06 | Verinata Health, Inc. | Identification of polymorphic sequences in mixtures of genomic DNA by whole genome sequencing |
| ES2704701T3 (es) | 2010-01-19 | 2019-03-19 | Verinata Health Inc | Nuevo protocolo de preparación de bibliotecas de secuenciación |
| WO2011103236A2 (en) | 2010-02-18 | 2011-08-25 | The Johns Hopkins University | Personalized tumor biomarkers |
| EP2426217A1 (en) | 2010-09-03 | 2012-03-07 | Centre National de la Recherche Scientifique (CNRS) | Analytical methods for cell free nucleic acids and applications |
| KR102040307B1 (ko) | 2010-11-30 | 2019-11-27 | 더 차이니즈 유니버시티 오브 홍콩 | 암과 연관된 유전적 또는 분자적 이상들의 검출 |
| GB2485635B (en) | 2011-07-26 | 2012-11-28 | Verinata Health Inc | Method for determining the presence or absence of different aneuploidies in a sample |
| WO2013052913A2 (en) | 2011-10-06 | 2013-04-11 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| WO2013060762A1 (en) * | 2011-10-25 | 2013-05-02 | Roche Diagnostics Gmbh | Method for diagnosing a disease based on plasma-dna distribution |
| US10214775B2 (en) | 2011-12-07 | 2019-02-26 | Chronix Biomedical | Prostate cancer associated circulating nucleic acid biomarkers |
| US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
| US9862995B2 (en) | 2012-03-13 | 2018-01-09 | Abhijit Ajit Patel | Measurement of nucleic acid variants using highly-multiplexed error-suppressed deep sequencing |
| US11261494B2 (en) | 2012-06-21 | 2022-03-01 | The Chinese University Of Hong Kong | Method of measuring a fractional concentration of tumor DNA |
| PL2893040T3 (pl) | 2012-09-04 | 2019-05-31 | Guardant Health Inc | Sposoby wykrywania rzadkich mutacji i wariantu liczby kopii |
| HK1217971A1 (zh) | 2013-02-21 | 2017-01-27 | Toma Biosciences Inc | 用於核酸分析的方法、組合物和試劑盒 |
| WO2014145078A1 (en) | 2013-03-15 | 2014-09-18 | Verinata Health, Inc. | Generating cell-free dna libraries directly from blood |
| US10174375B2 (en) | 2013-09-20 | 2019-01-08 | The Chinese University Of Hong Kong | Sequencing analysis of circulating DNA to detect and monitor autoimmune diseases |
| US10262755B2 (en) | 2014-04-21 | 2019-04-16 | Natera, Inc. | Detecting cancer mutations and aneuploidy in chromosomal segments |
| CN107002122B (zh) | 2014-07-25 | 2023-09-19 | 华盛顿大学 | 确定导致无细胞dna的产生的组织和/或细胞类型的方法以及使用其鉴定疾病或紊乱的方法 |
-
2013
- 2013-03-13 US US13/801,748 patent/US11261494B2/en active Active
- 2013-06-14 CN CN201711070698.4A patent/CN107779506B/zh active Active
- 2013-06-14 CA CA2876327A patent/CA2876327C/en active Active
- 2013-06-14 EP EP13807105.5A patent/EP2864501B1/en active Active
- 2013-06-14 KR KR1020187021883A patent/KR102096611B1/ko active Active
- 2013-06-14 IL IL311127A patent/IL311127B2/en unknown
- 2013-06-14 KR KR1020157001225A patent/KR101884909B1/ko active Active
- 2013-06-14 EP EP24201699.6A patent/EP4512907A3/en active Pending
- 2013-06-14 MX MX2014016058A patent/MX360264B/es active IP Right Grant
- 2013-06-14 JP JP2015517896A patent/JP6371280B2/ja active Active
- 2013-06-14 EP EP21185002.9A patent/EP3919627B1/en active Active
- 2013-06-14 CN CN201380042981.XA patent/CN104662168B/zh active Active
- 2013-06-14 KR KR1020227008276A patent/KR102521842B1/ko active Active
- 2013-06-14 KR KR1020217009799A patent/KR102375645B1/ko active Active
- 2013-06-14 AU AU2013278994A patent/AU2013278994C1/en active Active
- 2013-06-14 HU HUE18185290A patent/HUE056915T2/hu unknown
- 2013-06-14 PT PT18185290T patent/PT3456843T/pt unknown
- 2013-06-14 CA CA3080937A patent/CA3080937A1/en active Pending
- 2013-06-14 DK DK13807105.5T patent/DK2864501T3/en active
- 2013-06-14 KR KR1020247011005A patent/KR102720785B1/ko active Active
- 2013-06-14 ES ES13807105.5T patent/ES2687847T3/es active Active
- 2013-06-14 KR KR1020207009028A patent/KR102237923B1/ko active Active
- 2013-06-14 WO PCT/IB2013/054898 patent/WO2013190441A2/en not_active Ceased
- 2013-06-14 KR KR1020237012164A patent/KR102656030B1/ko active Active
- 2013-06-14 EA EA201500027A patent/EA037292B1/ru unknown
- 2013-06-14 EP EP18185290.6A patent/EP3456843B1/en active Active
- 2013-06-14 CN CN202110493949.XA patent/CN113151474A/zh active Pending
- 2013-06-14 EA EA202092900A patent/EA202092900A3/ru unknown
- 2013-06-14 ES ES18185290T patent/ES2894479T3/es active Active
- 2013-06-14 SG SG11201408113QA patent/SG11201408113QA/en unknown
- 2013-06-14 DK DK18185290.6T patent/DK3456843T3/da active
- 2013-06-14 IL IL298810A patent/IL298810B2/en unknown
- 2013-06-14 SG SG10201808217WA patent/SG10201808217WA/en unknown
- 2013-06-20 TW TW102122036A patent/TWI636255B/zh active
- 2013-06-20 TW TW107128593A patent/TWI803505B/zh active
- 2013-06-20 TW TW111143054A patent/TW202328458A/zh unknown
- 2013-06-20 TW TW109127987A patent/TWI786428B/zh active
-
2014
- 2014-11-27 IL IL235967A patent/IL235967B/en active IP Right Grant
- 2014-12-17 ZA ZA2014/09281A patent/ZA201409281B/en unknown
- 2014-12-19 MX MX2018013085A patent/MX2018013085A/es unknown
- 2014-12-19 MX MX2023001154A patent/MX2023001154A/es unknown
-
2017
- 2017-07-04 AU AU2017204558A patent/AU2017204558B2/en active Active
- 2017-12-22 US US15/853,288 patent/US20180202003A1/en active Pending
-
2018
- 2018-07-12 JP JP2018132118A patent/JP6930948B2/ja not_active Expired - Fee Related
-
2019
- 2019-05-08 US US16/406,715 patent/US20190264291A1/en not_active Abandoned
- 2019-08-12 IL IL26864519A patent/IL268645A/en active IP Right Grant
-
2020
- 2020-01-08 AU AU2020200122A patent/AU2020200122B2/en active Active
- 2020-11-19 IL IL278867A patent/IL278867B2/en unknown
-
2021
- 2021-08-12 JP JP2021131682A patent/JP7408161B2/ja active Active
-
2022
- 2022-07-28 AU AU2022209294A patent/AU2022209294A1/en not_active Abandoned
-
2023
- 2023-12-13 JP JP2023210140A patent/JP2024026360A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2023219906A1 (en) | Using size and number aberrations in plasma DNA for detecting cancer | |
| Hansen et al. | Shimmer: detection of genetic alterations in tumors using next-generation sequence data | |
| DK2823062T3 (en) | SIZE-BASED ANALYSIS OF Fetal DNA FRACTION IN MOTHER PLASMA | |
| IL311127B2 (en) | Mutational analysis of plasma DNA for cancer detection | |
| JP2015510757A5 (enExample) | ||
| CN106676178B (zh) | 一种评估肿瘤异质性的方法及系统 | |
| CN105243295A (zh) | 与癌症相关的遗传或分子畸变的检测 | |
| EP3518974A1 (en) | Noninvasive prenatal screening using dynamic iterative depth optimization | |
| JP2015536639A5 (enExample) | ||
| JP2014502155A5 (enExample) | ||
| Samad et al. | Imputation-based population genetics analysis of Plasmodium falciparum malaria parasites | |
| AU2019269742A1 (en) | Inferring selection in white blood cell matched cell-free DNA variants and/or in RNA variants | |
| Liu et al. | Personalised pathway analysis reveals association between DNA repair pathway dysregulation and chromosomal instability in sporadic breast cancer | |
| Esteves et al. | Probability distribution of copy number alterations along the genome: an algorithm to distinguish different tumour profiles | |
| CN116348957A (zh) | 检测测序数据中的交叉污染 | |
| JP2025509878A (ja) | 処置モニタリングのためのメチル化セルフリーｄｎａの分子計数 | |
| JP7332695B2 (ja) | 循環核酸からの全ゲノム配列データにおける包括的配列特徴の同定 | |
| JP6571526B2 (ja) | 鎖を除外することによりマイクロアレイの性能を向上する方法 | |
| KR20130125617A (ko) | 비정상 조직의 유전 정보를 분석하는 방법 및 장치 | |
| CN117953967A (zh) | 一种评估肿瘤纯度的方法、校正tmb的方法及设备 | |
| CN105316223A (zh) | 生物学样品分析系统及方法 | |
| US8255167B2 (en) | Non-hypergeometric overlap probability | |
| CN115762635A (zh) | 基于分子标记的用于肝癌筛查和风险预测的系统及应用 | |
| CN109411012B (zh) | 胶质母细胞瘤危险分层模型及其在临床预后评估的应用 | |
| CN112562787B (zh) | 一种基于ngs平台的基因大片段重排检测方法 |